Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | STS | P08842 | 4/20 | 0.33 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.32 |
| ▸ | PAM | P19021 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3454889 | 0.86 | HSD17B3 (0.40) | ELANEKMT2APAM | |
| SCHEMBL1261674 | 0.79 | ELANE (0.34) | ELANEKMT2ASMN1; SMN2TSHR | |
| SCHEMBL3454245 | 0.78 | ELANE (0.38) | ELANEKMT2ASMN1; SMN2TSHR | |
| SCHEMBL3454420 | 0.78 | ELANE (0.37) | ELANEKMT2ASMN1; SMN2 | |
| SCHEMBL6116870 | 0.76 | HSD11B1 (0.32) | ELANEKMT2ATSHR | |
| SCHEMBL3454435 | 0.76 | ELANE (0.35) | ELANEKMT2A | |
| SCHEMBL18785736 | 0.75 | DGKA (0.53) | KMT2APAMTSHR | |
| SCHEMBL18785733 | 0.75 | DGKA (0.53) | KMT2APAMTSHR | |
| SCHEMBL18785845 | 0.75 | DGKA (0.53) | KMT2APAMTSHR | |
| SCHEMBL18785847 | 0.75 | DGKA (0.53) | KMT2APAMTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8283102-B2 | Photoacid generator, copolymer, chemically amplified resist composition, and method of forming pattern using the chemically amplified resist composition | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2012-10-09 | — | — | US | disclosed |
| US-20100143843-A1 | PHOTOACID GENERATOR, COPOLYMER, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND METHOD OF FORMING PATTERN USING THE CHEMICALLY AMPLIFIED RESIST COMPOSITION | KOREA KUMHO PETROCHEMICAL CO., LTD. | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100143843-A1 | PHOTOACID GENERATOR, COPOLYMER, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND METHOD OF FORMING PATTERN USING THE CHEMICALLY AMPLIFIED RESIST COMPOSITION | POLL, PARG, POLH | ELANE 1905/4885PTGS2 3128/4885ESR1 179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.